BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Quipazine

A pharmacologic congener of serotonin that contracts smooth muscle and has actions similar to those of tricyclic antidepressants. It has been proposed as an oxytocic.

300+ PubMed studies analyzed · Evidence Score: 43.1

Research Domains

Quipazine has been studied across 20 research domains including 🌤️ Mood & Depression, 🧠 Focus & Attention, 😴 Sleep, 🧠 Learning, 🧬 Hormones. The primary research focus is 🌤️ Mood & Depression with 85% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Quipazine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Sumatriptan
12 shared targets
Bufotenin
12 shared targets
Metoclopramide
12 shared targets
Mescaline
12 shared targets
Vortioxetine
10 shared targets
brl
8 shared targets
chlorophenylpiperazine
8 shared targets
mebufotenin
8 shared targets
Mianserin
18 shared targets
5
7 shared targets
Loading evidence profile...

This evidence profile for Quipazine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.